Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey.

@article{Lip2013LeftAA,
  title={Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey.},
  author={Gregory Y. H. Lip and Nikolaos Dagres and Alessandro Proclemer and Jesper Hastrup Svendsen and Laurent P Pison and Carina Blomstrom-Lundqvist},
  journal={Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology},
  year={2013},
  volume={15 1},
  pages={141-3}
}
The purpose of this EP wire survey was to assess clinical practice in relation to the use of left atrial appendage occlusion (LAAO) devices for stroke prevention in atrial fibrillation (AF) among members of the European Heart Rhythm Association research network. The average number of performed LAAO was 10.6 per year and most (73%) centres performed ≤10 procedures per year. We found that LAAO was being performed for stroke prevention in AF, for the most common indication being 'the patient has… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 11 references

How does left atrial appendage occlusion using the watchman device compare to dabigatran for reducing thromboembolic events in patients with nonvalvular atrial fibrillation

  • S Kaul, E Cigolani, M Shehata, GA. Diamond
  • J Am Coll Cardiol 2010;55:A4.E39 (abstract)
  • 2010
1 Excerpt

Watchman delayed: FDA wants more data on the LAA-closure device before approving

  • M. O’Riordan
  • The heart. Org. [clinical conditions . arrhythmia…
  • 2010
1 Excerpt

Similar Papers

Loading similar papers…